Xiaofei Zhang, MD

Shanghai cancer hospital

Shanghai, shanghai

Disclosures:

Employment: none
Compensation: none
Ownership: none
Leadership: none

Presentations

Sep 27

2288 - Efficacy and Prognosis of Neoadjuvant Chemoimmunotherapy Followed by Concurrent Chemoradiotherapy in Unresectable Esophageal Cancer: The First Single-Center Real-World Study

03:00pm - 04:00pm ET